Tove Olafsen

City Of Hope National Medical Center — United States

Medicine · Health Sciences

34h-index3.5kcitations134works0.92yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(69), Radiopharmaceutical Chemistry and Applications(56), CAR-T cell therapy research(26), Medical Imaging and Pathology Studies(22), Medical Imaging Techniques and Applications(15)

Publications133 total

A pilot study of healing critical-sized calvarial defects by LL-37-generated monoosteophils
Frontiers in Bioengineering and Biotechnology·2025Open Access
First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomy
European Journal of Nuclear Medicine and Molecular Imaging·2024· 17 citedOpen Access
Figure S7 from <sup>89</sup>Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
2024Open Access
Figure S3 from <sup>89</sup>Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
2024Open Access
Supplemental Tables from <sup>89</sup>Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
2024Open Access
Figure S6 from <sup>89</sup>Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
2024Open Access
Figure S5 from <sup>89</sup>Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
2024Open Access
Figure S6 from <sup>89</sup>Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
2024Open Access
Data from <sup>89</sup>Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
2024Open Access
Data from <sup>89</sup>Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
2024Open Access
Supplemental Tables from <sup>89</sup>Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
2024Open Access
Figure S4 from <sup>89</sup>Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
2024Open Access
Supplementary Data from <sup>89</sup>Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
2024Open Access
Supplementary Data from <sup>89</sup>Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
2024Open Access
Figure S1 from <sup>89</sup>Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
2024Open Access
Figure S2 from <sup>89</sup>Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
2024Open Access
Figure S1 from <sup>89</sup>Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
2024Open Access
Figure S5 from <sup>89</sup>Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
2024Open Access
Figure S4 from <sup>89</sup>Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
2024Open Access
Figure S3 from <sup>89</sup>Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
2024Open Access
page 1 of 7Next →

Frequent Co-authors

Anna M. Wu(39), Vania Kenanova(13), Andrew Raubitschek(10), John E. Shively(8), Lawrence E. Williams(7), Paul J. Yazaki(6), Sanjiv S. Gambhir(6), Felix B. Salazar(5), Katelyn E. McCabe(5), Mark A. Sherman(4), Jeffrey V. Leyton(4), Robert E. Reiter(4), Karl B. Bauer(4), Shannon J. Sirk(4), Gobalakrishnan Sundaresan(3), Jonathan Said(3), Eric J. Lepin(3), Bhaswati Barat(3), Michael Torgov(3), Mark D. Girgis(3)